A research team from Beth Israel Deaconess Medical Center finds that the RBP4 protein acts like a foreign pathogen to trigger inflammation of fat tissue -- and diabetes risk.
3/6/2014 10:00 AM EST
BOSTON – Call it what you will – getting red in the face, hot under the collar, losing your cool, blowing your top – we all experience anger. And while we know that anger is a normal, sometimes even beneficial emotion, we‘re also aware of...
3/3/2014 12:00 PM EST
A scientific team from Beth Israel Deaconess Medical Center has made a surprising discovery about the brain's hunger-inducing neurons, a finding with important implications for the treatment of obesity
2/7/2014 10:00 AM EST
Investigators from Beth Israel Deaconess Medical Center help explain why diabetes patients are at risk for microvascular complications
1/31/2014 4:00 PM EST
BIDMC Aims To Engage Patients and Family In Effort to Eliminate Preventable Harm in Intensive Care Units
BOSTON – Beth Israel Deaconess Medical Center is embarking on a new phase of its mission to eliminate preventable harm, using information technology and system science together with patient and family engagement to head off harm before it happens
1/24/2014 2:00 PM EST
Beth Israel Deaconess Medical Center (BIDMC) yesterday became the first institution in the United States to use a new minimally invasive medical device since it received FDA approval last week. The device treats patients with severely damaged...
1/23/2014 1:00 PM EST
While weight loss surgery offers one of the best opportunities to improve health and reduce obesity related illnesses, the nearly 100,000 Americans who undergo bariatric surgery each year represent only a small fraction of people who are medically...
1/6/2014 10:00 AM EST
Beth Israel Deaconess Medical Center Expands Partnership with Pfizer’s Centers for Therapeutic Innovation to Include Focus on Small Molecule Drug Targets
Beth Israel Deaconess Medical Center (BIDMC) announced today the expansion of its partnership with Pfizer’s Centers for Therapeutic Innovation (CTI) into the identification and development of small-molecule drug candidates. This agreement, the...
12/4/2013 3:55 PM EST